Clinical outcome in metastatic prostate cancer after primary radiotherapy.
Matthias MollHarald HerrmannAlexandru ZaharieGregor GoldnerPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2022)
DM was associated with significantly worse outcomes than NM. The long-term survival of patients with metastatic prostate cancer was low.